-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Earlier, Mesoblast's FDA-Approved Ryoncil Gets IND Clearance For Registrational DMD Trial, To Randomize 76 Patients Aged 5-9 Years Across 7 Infusions Over 9 Months

Benzinga·04/08/2026 06:33:25
Listen to the news

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients

~15,000 children are living with DMD in the U.S.